Associated Vitreoretinal and Uveitis Consultants — Indianapolis, Indiana

Associated Vitreoretinal and Uveitis Consultants is a clinical research site located in Indianapolis, Indiana, United States 46290.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Associated Vitreoretinal and Uveitis Consultants has participated in 1 clinical trials.

Therapeutic areas: Low-grade Serous Ovarian Cancer, Low-grade Serous Fallopian Tube Cancer, Low-grade Serous Peritoneal Cancer.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Associated Vitreoretinal and Uveitis Consultants?

Associated Vitreoretinal and Uveitis Consultants has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Associated Vitreoretinal and Uveitis Consultants conducted?

Associated Vitreoretinal and Uveitis Consultants has 1 clinical trials on record. Their work covers Low-grade Serous Ovarian Cancer, Low-grade Serous Fallopian Tube Cancer, Low-grade Serous Peritoneal Cancer.

Is Associated Vitreoretinal and Uveitis Consultants accredited by Crixeo Clinical Trials?

Associated Vitreoretinal and Uveitis Consultants has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Associated Vitreoretinal and Uveitis Consultants?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.